Synthesis of hemslecin A derivatives: A new class of hepatitis B virus inhibitors

被引：17

作者：

Guo, Rui-Hua ^{[1
]}

Geng, Chang-An ^{[1
]}

Huang, Xiao-Yan ^{[1
]}

Ma, Yun-Bao ^{[1
]}

Zhang, Quan ^{[1
]}

Wang, Li-Jun ^{[1
]}

Zhang, Xue-Mei ^{[1
]}

Zhang, Rong-Ping ^{[2
]}

Chen, Ji-Jun ^{[1
]}

机构：

[1] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming 650204, Peoples R China

[2] Kunming Med Univ, Kunming 650500, Yunnan, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 05期

基金：

中国国家自然科学基金;

关键词：

Hemslecin A; Derivatives; Hepatitis B virus; SCHISANDRA-WILSONIANA; FRUITS; ALISOL;

D O I：

10.1016/j.bmcl.2013.01.024

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of hemslecin A derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activities, namely, inhibiting the secretion of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and HBV DNA replication on HepG 2.2.15 cells. Most of the derivatives showed enhanced anti-HBV activities, of which compounds A1-A7, B5, C and E exhibited significant activities inhibiting HBV DNA replication with IC50 values of 2.8-11.6 mu M, comparable to that of the positive control, tenofovir. Compounds A1-A3, A5, B5, and C displayed low cytotoxicities, which resulted in high SI values of 89.7, 55.6, 77.8, >83.4, >55.8, and >150.5, respectively. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.

引用

页码：1201 / 1205

页数：5

共 50 条

[1] Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors
Geng, Chang-An
Huang, Xiao-Yan
Ma, Yun-Bao
Zhang, Xue-Mei
Chen, Ji-Jun
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (07) : 1568 - 1571
[2] Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: A new class of hepatitis B virus inhibitors
Zhang, Quan
Jiang, Zhi-Yong
Luo, Jie
Cheng, Pi
Ma, Yun-Bao
Zhang, Xue-Mei
Zhang, Feng-Xue
Zhou, Jun
Chen, Ji-Jun
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) : 4647 - 4650
[3] Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus
Luo, Yu
Yao, Jia-Ping
Yang, Li
Feng, Chun-Lan
Tang, Wei
Wang, Gui-Feng
Zuo, Jian-Pin
Lu, Wei
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (14) : 5048 - 5055
[4] NEW THIOUREA DERIVATIVES AS POTENT INHIBITORS OF HEPATITIS B VIRUS FOR THERAPEUTIC TARGETING
Kumar, Jitendra
Kumar, Vijay
HEPATOLOGY, 2022, 76 : S316 - S317
[5] Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication
Perni, RB
Conway, SC
Ladner, SK
Zaifert, K
Otto, MJ
King, RW
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (23) : 2687 - 2690
[6] Synthesis of hepatitis B virus fusion inhibitors
Schieck, Alexa
Mueller, Thomas
Boy, Garcia Regine
Urban, Stephan
Kunz, Horst
Mier, Walter
JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 62 - 62
[7] Design, synthesis, and biological evaluation of sulfamaoylbenzamide derivatives as hepatitis B virus capsid inhibitors
Hyogyeong, Na
Kim, Hyejin
Jung, Young-Sik
Han, Soo Bong
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
[8] Synthesis of celastrol derivatives as potential non-nucleoside hepatitis B virus inhibitors
Zhang, He
Lu, Gongxi
CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 96 (06) : 1380 - 1386
[9] Synthesis and Anti-Hepatitis B Virus Activity of a Novel Class of Thiazolylbenzimidazole Derivatives
Luo, Yu
Yao, Jia-Ping
Yang, Li
Feng, Chun-Lan
Tang, Wei
Wang, Gui-Feng
Zuo, Jian-Pin
Lu, Wei
ARCHIV DER PHARMAZIE, 2011, 344 (02) : 78 - 83
[10] New class of small molecule inhibitors of hepatitis B virus surface antigen secretion
Cuconati, A
Westby, G
Mehta, A
Block, T
ANTIVIRAL RESEARCH, 2005, 65 (03) : A56 - A56

← 1 2 3 4 5 →